Paper23636668
Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry.
Lee JW and 8 others. Int J Hematol, 2013. Cited by 101 papers, by iCite.
Cite this record
ConductScience Library. Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry. Papers, record 23636668. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23636668
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Clinical signs and symptoms associated with increased risk for thrombosis in patients with paroxysmal nocturnal hemoglobinuria from a Korean Registry.
- PubMed
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hemoglobinuria, Paroxysmal | Major topic |
| Thrombosis | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Child | |
| Female | |
| Humans | |
| Lactate Dehydrogenases | |
| Male | |
| Middle Aged | |
| Prognosis | |
| ROC Curve | |
| Registries | |
| Republic of Korea | |
| Retrospective Studies | |
| Risk Factors | |
| Thromboembolism | |
| Young Adult |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01224483 | Multicenter Retrospective Analysis About the Clinical Characteristics of Korean Paroxysmal Nocturnal Hemoglobinuria (PNH) Patients | Derived from the trial | Yes |
Source ClinicalTrials.gov
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 15985537 | Sustained response and long-term safety of eculizumab in paroxysmal nocturnal hemoglobinuria. | Blood | 2005 | https://conductscience.org/library/papers/15985537 | PubMed |
| 2 | 20433987 | Thrombosis in Paroxysmal Nocturnal Hemoglobinuria - insights into the role of complement in thrombosis. | Thromb Res | 2010 | https://conductscience.org/library/papers/20433987 | PubMed |
| 3 | 22639982 | Under-recognized complications in patients with paroxysmal nocturnal haemoglobinuria: raised pulmonary pressure and reduced right ventricular function. | Br J Haematol | 2012 | https://conductscience.org/library/papers/22639982 | PubMed |
| 4 | 15811985 | The clinical sequelae of intravascular hemolysis and extracellular plasma hemoglobin: a novel mechanism of human disease. | JAMA | 2005 | https://conductscience.org/library/papers/15811985 | PubMed |
| 5 | 1578962 | Hemolytic anemias. Diagnosis and management. | Med Clin North Am | 1992 | https://conductscience.org/library/papers/1578962 | PubMed |
| 6 | 7688991 | Complement-induced vesiculation and exposure of membrane prothrombinase sites in platelets of paroxysmal nocturnal hemoglobinuria. | Blood | 1993 | https://conductscience.org/library/papers/7688991 | PubMed |
| 7 | 8774569 | Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. French Society of Haematology. | Lancet | 1996 | https://conductscience.org/library/papers/8774569 | PubMed |
| 8 | 18055865 | Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. | Blood | 2008 | https://conductscience.org/library/papers/18055865 | PubMed |
| 9 | 16464755 | Improvement in the symptoms of smooth muscle dystonia during eculizumab therapy in paroxysmal nocturnal hemoglobinuria. | Haematologica | 2005 | https://conductscience.org/library/papers/16464755 | PubMed |
| 10 | 21455865 | Thrombosis in patients with paroxysmal nocturnal hemoglobinuria. | Semin Thromb Hemost | 2011 | https://conductscience.org/library/papers/21455865 | PubMed |
| 11 | 7539996 | Nitric oxide in the regulation of blood flow and arterial pressure. | Annu Rev Physiol | 1995 | https://conductscience.org/library/papers/7539996 | PubMed |
| 12 | 16051736 | Diagnosis and management of paroxysmal nocturnal hemoglobinuria. | Blood | 2005 | https://conductscience.org/library/papers/16051736 | PubMed |
| 13 | 21460245 | Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. | Blood | 2011 | https://conductscience.org/library/papers/21460245 | PubMed |
| 14 | 17702897 | Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. | Blood | 2007 | https://conductscience.org/library/papers/17702897 | PubMed |
| 15 | 21447004 | Natural history of paroxysmal nocturnal hemoglobinuria clones in patients presenting as aplastic anemia. | Eur J Haematol | 2011 | https://conductscience.org/library/papers/21447004 | PubMed |
| 16 | 20658586 | Long-term effect of the complement inhibitor eculizumab on kidney function in patients with paroxysmal nocturnal hemoglobinuria. | Am J Hematol | 2010 | https://conductscience.org/library/papers/20658586 | PubMed |
| 17 | 15118546 | Clinical course and flow cytometric analysis of paroxysmal nocturnal hemoglobinuria in the United States and Japan. | Medicine (Baltimore) | 2004 | https://conductscience.org/library/papers/15118546 | PubMed |
| 18 | 16990386 | The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. | N Engl J Med | 2006 | https://conductscience.org/library/papers/16990386 | PubMed |
| 19 | 8500164 | Deficiency of the GPI anchor caused by a somatic mutation of the PIG-A gene in paroxysmal nocturnal hemoglobinuria. | Cell | 1993 | https://conductscience.org/library/papers/8500164 | PubMed |
| 20 | 12893760 | Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). | Blood | 2003 | https://conductscience.org/library/papers/12893760 | PubMed |
Cited by64
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 101 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42287326 | Efficacy and safety of crovalimab versus eculizumab in complement inhibitor-naïve patients with paroxysmal nocturnal hemoglobinuria: Chinese subgroup analysis of the phase 3 COMMODORE 2 study. | Ann Hematol | 2026 | https://conductscience.org/library/papers/42287326 | PubMed |
| 41832377 | Thrombosis in paroxysmal nocturnal hemoglobinuria in the complement inhibitor era: mechanisms, risk stratification, and clinical management. | Int J Hematol | 2026 | https://conductscience.org/library/papers/41832377 | PubMed |
| 40986193 | Pharmacological Therapies in Paroxysmal Nocturnal Haemoglobinuria: Focus on Complement Inhibition. | Drugs | 2025 | https://conductscience.org/library/papers/40986193 | PubMed |
| 40886199 | Clinical characteristics and management of paroxysmal nocturnal hemoglobinuria in the Middle East: a narrative review. | Clin Exp Med | 2025 | https://conductscience.org/library/papers/40886199 | PubMed |
| 40849394 | Clinical Outcomes and Disease Management for Patients with Paroxysmal Nocturnal Haemoglobinuria in China: Results from a Real-World Study. | Drugs Real World Outcomes | 2025 | https://conductscience.org/library/papers/40849394 | PubMed |
| 40844514 | PNH clones prevalence study in ph-negative myeloproliferative neoplasms: a multicenter Italian study. | Ann Hematol | 2025 | https://conductscience.org/library/papers/40844514 | PubMed |
| 40141144 | Prevention and Management of Thromboembolism in Patients with Paroxysmal Nocturnal Hemoglobinuria in Asia: A Narrative Review. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40141144 | PubMed |
| 39596227 | Monitoring and Treatment of Paroxysmal Nocturnal Hemoglobinuria in Patients with Aplastic Anemia in Asia: An Expert Consensus. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596227 | PubMed |
| 39596172 | Thrombosis in Paroxysmal Nocturnal Hemoglobinuria (PNH): From Pathogenesis to Treatment. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39596172 | PubMed |
| 39201278 | Moving toward Individual Treatment Goals with Pegcetacoplan in Patients with PNH and Impaired Bone Marrow Function. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39201278 | PubMed |
| 39134485 | [Analysis and summary of clinical characteristics of 289 patients with paroxysmal nocturnal hemoglobinuria in Zhejiang Province]. | Zhonghua Xue Ye Xue Za Zhi | 2024 | https://conductscience.org/library/papers/39134485 | PubMed |
| 38702811 | Health-related quality of life and influencing factors of patients with paroxysmal nocturnal hemoglobinuria in China. | Orphanet J Rare Dis | 2024 | https://conductscience.org/library/papers/38702811 | PubMed |
| 38541928 | Fatigue Item Response among Hemoglobin-Normalized Patients with Paroxysmal Nocturnal Hemoglobinuria: PEGASUS Trial Results at 16 and 48 Weeks. | J Clin Med | 2024 | https://conductscience.org/library/papers/38541928 | PubMed |
| 38442722 | Impact of Lactate Dehydrogenase and Hemoglobin Levels on Clinical Outcomes in Patients With Paroxysmal Nocturnal Hemoglobinuria: Results From the National Korean PNH Registry. | J Korean Med Sci | 2024 | https://conductscience.org/library/papers/38442722 | PubMed |
| 38084255 | Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations. | J Blood Med | 2023 | https://conductscience.org/library/papers/38084255 | PubMed |
| 37668788 | Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case-control study in the International PNH Registry. | Ann Hematol | 2023 | https://conductscience.org/library/papers/37668788 | PubMed |
| 37564039 | Swiss Survey on current practices and opinions on clinical constellations triggering the search for PNH clones. | Front Med (Lausanne) | 2023 | https://conductscience.org/library/papers/37564039 | PubMed |
| 37428869 | Complement and platelets: prothrombotic cell activation requires membrane attack complex-induced release of danger signals. | Blood Adv | 2023 | https://conductscience.org/library/papers/37428869 | PubMed |
| 37298309 | The Effect of Respiratory Viral Infections on Breakthrough Hemolysis in Patients with Paroxysmal Nocturnal Hemoglobinuria. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37298309 | PubMed |
| 37199789 | Relationship of paroxysmal nocturnal hemoglobinuria (PNH) granulocyte clone size to disease burden and risk of major vascular events in untreated patients: results from the International PNH Registry. | Ann Hematol | 2023 | https://conductscience.org/library/papers/37199789 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/23636668
GET https://conductscience.org/api/papers/v1/23636668/references?page=2